Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and GlioblastomaCrismita Dmello, Aarón Sonabend, Victor A Arrieta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Pharmacokinetic analysis of carboplatin and fluorescein brain retention following ultrasound-based blood-brain barrier openingKarl J Habashy, Timothy W Synold, Ye Feng, et al.
Acta Neuropathologica|September 25, 2016
Mutant IDH1 and thrombosis in gliomasDusten Unruh, Steven R Schwarze, Laith Khoury, et al.
Brain, Behavior, & Immunity - Health|April 11, 2024
Age-stratified comorbid and pharmacologic analysis of patients with glioblastomaErik E Rabin, Jonathan Huang, Miri Kim, et al.
The Lancet. Oncology|May 4, 2023
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trialAdam M Sonabend, Andrew Gould, Christina Amidei, et al.
Neuro-Oncology|December 1, 2021
Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trialE Antonio Chiocca, Arnold B Gelb, Clark C Chen, et al.
The Lancet. Oncology|July 2, 2021
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trialJawad Fares, Atique U Ahmed, Ilya V Ulasov, et al.
Nature Communications|December 16, 2025
Dynamic release of extracellular particles after opening of the blood-brain barrier predicts glioblastoma susceptibility to paclitaxelMark W Youngblood, Abha Kumari, Yoon-Tae Kang, et al.
Neuro-Oncology|July 19, 2024
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomasKwang-Soo Kim, Karl Habashy, Andrew Gould, et al.
Nature Communications|June 6, 2024
Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomasVíctor A Arrieta, Andrew Gould, Kwang-Soo Kim, et al.
Pageof 4